BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Aeris Therapeutics, Inc. Bolsters Executive Management Team with Key Appointments for Initial Commercialization of Advanced Emphysema Therapy


6/28/2011 10:56:02 AM

WOBURN, Mass.--(BUSINESS WIRE)--Aeris Therapeutics, LLC today announced the appointments of Dennis D’Oria as its new Vice President of International Sales and Marketing and Mr. Charles R. Carter as Chief Financial Officer. “Aeris has made great strides in the development phase of the AeriSeal® System,” said David Dove, M.D., President and CEO. “Dennis and Charley bring a great deal of combined experience that will enable us to drive our commercialization efforts. We are eager to make the clinical benefits of the AeriSeal System available to as many patients suffering with advanced emphysema as possible.”

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES